Takaichi K, Miyajima Y, Hanai J I, Kurokawa K, Fujita T, Warnock D G
Fourth Department of Internal Medicine, University of Tokyo School of Medicine, Japan.
J Cell Physiol. 1999 Jan;178(1):44-50. doi: 10.1002/(SICI)1097-4652(199901)178:1<44::AID-JCP6>3.0.CO;2-O.
Some epithelial cells have Na+/H+ exchanger (NHE) activity in both apical and basolateral membranes. Amiloride-sensitive NHE-1 is generally identified in the basolateral membrane. The renal cell line, OK7a, targets amiloride-resistant NHE predominantly to the apical membrane. It is controversial whether the transfected NHE-1 is targeted preferentially to the basolateral membrane in OK7a cells, when human NHE-1 is chronically expressed under control of constitutively active promoters. We tried to identify the membranes in which the transfected human NHE-1 could be detected following acute expression in OK7a cells. We have always observed small Na(+)-dependent pH recovery in the basolateral membrane in OK7a cells. It is, however, controversial whether or not OK7a cells express NHE activity in the basolateral membrane. We also characterized Na(+)-dependent pH recovery in the basolateral membrane. It was not inhibited by [4,4'diisothiocyanatostilbene-2,2'-disulfonic acid] (DIDS), [4-acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic acid] (SITS), or contralateral amiloride. Li+ but not K+, chol+, or NMG+ could replace Na+. These results are consistent with the presence of the NHE in the basolateral membrane. NHE activities were predominant in the apical membrane and those in both membranes were resistant to amiloride analogs. After stable transfection with human NHE-1 in a vector utilizing the metallothionein promoter, overnight induction with Zn(2+)increased the NHE activity and its sensitivity to amiloride only in the basolateral membrane in OK7a cells. We conclude that the transfected human NHE-1 is exclusively targeted to the basolateral membrane of OK7a cells during acute induction.
一些上皮细胞在顶端膜和基底外侧膜上均具有Na⁺/H⁺交换体(NHE)活性。氨氯地平敏感的NHE-1通常在基底外侧膜中被识别。肾细胞系OK7a主要将氨氯地平耐药的NHE靶向至顶端膜。当人NHE-1在组成型活性启动子的控制下长期表达时,转染的NHE-1是否优先靶向OK7a细胞的基底外侧膜存在争议。我们试图确定在OK7a细胞中急性表达后可检测到转染人NHE-1的膜。我们一直观察到OK7a细胞基底外侧膜中存在小的Na⁺依赖性pH恢复。然而,OK7a细胞在基底外侧膜中是否表达NHE活性存在争议。我们还对基底外侧膜中Na⁺依赖性pH恢复进行了表征。它不受[4,4'-二异硫氰酸根合芪-2,2'-二磺酸](DIDS)、[4-乙酰氨基-4'-异硫氰酸根合芪-2,2'-二磺酸](SITS)或对侧氨氯地平的抑制。Li⁺而非K⁺、胆碱⁺或N-甲基-D-葡萄糖胺⁺可替代Na⁺。这些结果与基底外侧膜中存在NHE一致。NHE活性在顶端膜中占主导,且两个膜中的活性均对氨氯地平类似物耐药。在用利用金属硫蛋白启动子的载体稳定转染人NHE-1后,用Zn²⁺过夜诱导仅增加了OK7a细胞基底外侧膜中的NHE活性及其对氨氯地平的敏感性。我们得出结论,在急性诱导期间,转染的人NHE-1仅靶向OK7a细胞的基底外侧膜。